In this scenario, we aimed to investigate some molecular mechanisms underlying adiponectin action in MS, finding that the administration of AdipoRon can facilitate neuronal and glial survival by the recovery of MS-CSF-induced viability inhibition. The gene discussed is ADIPOQ; the disease is myeloid sarcoma.